How can AI in diabetic retinopathy screening be introduced, and what are its potential benefits and pitfalls? Professor Peter Scanlon shares his experiences. He also talks about the impact of obesity on the prevalence of diabetes globally and how this varies between different racial groups. Finally, he touches on how improved glycemic control with modern insulin delivery systems has reduced the incidence of sight threatening retinopathy.

Don’t forget to check out our subscriber content and self-directed CPD material on our Eyes On Tomorrow Substack.

Produced by Matt Hill at Rethink Audio.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe